Open AccessGastrointestinal symptoms are associated with trajectories of chemotherapy-induced nausea
Author(s) -
Komal Singh,
Kord M. Kober,
Steven M. Paul,
Marilyn J. Hammer,
Fay Wright,
Yvette P. Conley,
Jon D. Levine,
Christine Miaskowski
Publication year - 2019
Publication title -
supportive care in cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.133
H-Index - 112
eISSN - 1433-7339
pISSN - 0941-4355
DOI - 10.1007/s00520-019-05031-5
Subject(s) - medicine , nausea , vomiting , chemotherapy , constipation , etiology , gastroenterology , comorbidity , chemotherapy regimen , chemotherapy induced nausea and vomiting , breast cancer , regimen , swallowing , cancer , antiemetic , surgery
Between 19 and 58% of oncology patients experience chemotherapy-induced nausea (CIN). In a sample of outpatients with breast, gastrointestinal (GI), gynecological, and lung cancer, the study purposes were to evaluate for inter-individual differences in the severity of CIN over two cycles of chemotherapy (CTX) and to determine which demographic and clinical characteristics and GI symptoms were associated with higher initial levels as well as with the trajectories of CIN severity.